In today’s rapidly evolving pharmaceutical landscape, sustainable growth is no longer driven by scale alone—it is built on ethics, quality, transparency, and long-term partnerships. The PCD (Propaganda Cum Distribution) Pharma model has emerged as a powerful framework that enables pharmaceutical companies and entrepreneurs to grow together while ensuring accessibility, affordability, and trust in healthcare delivery.
At Zee Laboratories Limited, we are committed to strengthening this ecosystem by empowering our PCD partners with robust systems, high-quality products, and ethical business practices.
Understanding the PCD Pharma Model
The PCD Pharma model allows distributors and entrepreneurs to market pharmaceutical products under a company’s brand name within a defined geographic territory. This structure offers monopoly rights, operational independence, and scalable growth opportunities—making it one of the most preferred models in the Indian pharmaceutical industry.
What differentiates a successful PCD ecosystem is not just product availability, but the depth of support, compliance standards, and business integrity provided by the parent organization.
Ethics as the Foundation of Growth
An ethical pharmaceutical ecosystem ensures:
- Compliance with regulatory and quality standards
- Transparent pricing and fair margins
- Responsible promotion and marketing practices
- Patient-centric product availability
Zee Laboratories Limited follows a strict quality-first approach, ensuring that every formulation meets defined safety, efficacy, and regulatory benchmarks. Ethical operations build trust—not only with partners but also with healthcare professionals and patients.
Scalable Infrastructure & Manufacturing Excellence
A scalable PCD ecosystem requires dependable manufacturing strength. Zee Laboratories operates with 7 WHO-GMP certified manufacturing units, enabling consistent supply, quality assurance, and portfolio expansion across therapeutic segments.
With 5,000+ formulations across multiple dosage forms, we support PCD partners in addressing diverse market demands—from acute therapies to chronic care segments.
Diverse PCD Divisions for Targeted Growth
To ensure focused and specialized market penetration, Zee Laboratories offers 23+ PCD divisions, covering:
- General medicines
- Super specialty segments
- Nutraceuticals
- Dermatology
- Herbal and wellness products
- Veterinary and allied healthcare
This division-based approach allows partners to build strong brand recall within specific therapeutic categories, enhancing both credibility and profitability.
General Division
Zee Laboratories | Lanark | Klokter | Axyzen | Bionext | Wel’n’Drugs | Deventure | Medibruck | Grentek | Cecel | ADPL
Super Specialty Division
Oreva | Biorome | Dermazest | Bio Beauty London | Concord | Cardiways | Altrex | Bioleys | Vetlife | Petbest | Zee Herbal | Vision Care | Zee Nutrition
Strong Partner Enablement System
A successful PCD partnership extends beyond product supply. Zee Laboratories provides:
- Monopoly rights for defined territories
- Comprehensive promotional inputs
- Strategic marketing support
- Consistent product availability
- Dedicated business coordination
With 3,000+ business partners across India and overseas markets, our ecosystem reflects reliability, collaboration, and long-term vision.
Expanding Beyond Domestic Markets
In addition to PCD operations, Zee Laboratories has a strong presence in 50+ export countries, along with Government Supplies (Central & State) and institutional business including defence, railways, and public healthcare systems. This diversified operational base strengthens the stability and credibility of the overall ecosystem.
Building the Future of Ethical Pharma Partnerships
The future of the pharmaceutical industry lies in responsible expansion, collaborative growth, and uncompromising quality standards. The PCD model, when backed by a strong organization, becomes a catalyst for entrepreneurship and healthcare accessibility.
At Zee Laboratories Limited, we continue to build an ecosystem where partners grow with confidence, ethics drive decisions, and quality defines outcomes.
Conclusion
PCD is not merely a distribution model—it is a strategic partnership framework. By combining ethical business practices, scalable infrastructure, and partner-centric support, Zee Laboratories Limited is actively shaping a stronger and more sustainable pharmaceutical ecosystem.
